Remy Sukhija

2020

In 2020, Remy Sukhija earned a total compensation of $3.4M as Senior Vice President, Chief Commercial Officer at Synta Pharmaceuticals.

Compensation breakdown

Bonus$100,000
Non-Equity Incentive Plan$274,680
Option Awards$2,724,000
Salary$337,500
Other$2,722
Total$3,438,902

Sukhija received $2.7M in option awards, accounting for 79% of the total pay in 2020.

Sukhija also received $100K in bonus, $274.7K in non-equity incentive plan, $337.5K in salary and $2.7K in other compensation.

Rankings

In 2020, Remy Sukhija's compensation ranked 3,375th out of 13,090 executives tracked by ExecPay. In other words, Sukhija earned more than 74.2% of executives.

ClassificationRankingPercentile
All
3,375
out of 13,090
74th
Division
Manufacturing
1,314
out of 5,618
77th
Major group
Chemicals And Allied Products
499
out of 2,251
78th
Industry group
Drugs
433
out of 1,951
78th
Industry
Pharmaceutical Preparations
324
out of 1,456
78th
Source: SEC filing on May 2, 2022.

Sukhija's colleagues

We found four more compensation records of executives who worked with Remy Sukhija at Synta Pharmaceuticals in 2020.

2020

Paul Friedman

Synta Pharmaceuticals

Chief Executive Officer

2020

Brian Lynch

Synta Pharmaceuticals

General Counsel

2020

Rebecca Taub

Synta Pharmaceuticals

Chief Medical Officer

2020

Marc Schneebaum

Synta Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like